SCHEMBL31072603

CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O

nearest known ligand 0.74

Predicted protein targets (top 13)

	gene	UniProt	supporting neighbours	confidence
▸	TFPI	P10646	7/20	0.72

▸	NMUR2	Q9GZQ4	3/20	0.66

▸	NMUR1	Q9HB89	3/20	0.66

▸	NPY2R	P49146	6/20	0.66

▸	NPY4R	P50391	6/20	0.66

▸	NPY5R	Q15761	6/20	0.66

▸	NPY1R	P25929	4/20	0.66

▸	KDM1A	O60341	2/20	0.65

▸	MAOB	P27338	1/20	0.64

▸	KDM5A	P29375	1/20	0.64

▸	KDM1B	Q8NB78	1/20	0.64

▸	RAMP3	O60896	1/20	0.64

▸	CALCR	P30988	1/20	0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31105502	0.95	NMUR2 (0.72)	TFPINMUR2NMUR1NPY2RNPY4R
SCHEMBL31072567	0.93	NMUR2 (0.68)	TFPINMUR2NMUR1
SCHEMBL29361709	0.92	TFPI (0.71)	TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL29533414	0.91	TFPI (0.70)	TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL30432104	0.90	TFPI (0.69)	TFPINMUR2NMUR1NPY2RNPY4R
SCHEMBL31182566	0.90	TFPI (0.68)	TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL30495778	0.90	NPY2R (0.69)	TFPINMUR2NMUR1NPY2RNPY4R
SCHEMBL29434542	0.89	TFPI (0.68)	TFPINMUR2NMUR1NPY2RNPY4R
SCHEMBL30423064	0.89	KEAP1 (0.69)	TFPINMUR2NMUR1NPY2RNPY4R
SCHEMBL30883233	0.89	NMUR2 (0.68)	TFPINMUR2NMUR1NPY2RNPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20260015393-A1	NOVEL NMU RECEPTOR 2 AGONISTS	BOEHRINGER INGELHEIM INT (DE)	2026-01-15	—	—	US	disclosed
US-20240279278-A1	NMU RECEPTOR 2 AGONISTS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE)	2024-08-22	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20260015393-A1	NOVEL NMU RECEPTOR 2 AGONISTS	NMUR2, NMUR1, GPR18	TFPI 3279/4885NMUR2 1/4885NMUR1 2/4885
US-20240279278-A1	NMU RECEPTOR 2 AGONISTS	NMUR2, NMUR1, NMBR	TFPI 2855/4885NMUR2 1/4885NMUR1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.